Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Consider increased clinical or laboratory monitoring when co-administered with other oral medications that have a narrow therapeutic index or that require clinical monitoring
Retatrutide is often called a triple agonist because it activates three hormone receptor pathways: GLP-1 (involved in appetite, satiety, and glucose regulation), GIP (involved in insulin response and metabolic signaling), and glucagon (involved in energy expenditure and fat metabolism)
According to a 2024 report by Harvard Health, the Food and Drug Administration has approved a total of 10 GLP-1 medications for treating diabetes and obesity, with other applications like drug addiction still being studied
It is involved in energy metabolism and recycling glutathione
US$ 26.32
US$ 26.63
US$ 22.84
